Jonathan Myles, MD
Genitourinary Pathology
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
MaleAbout Jonathan Myles
Biography
Jonathan Myles, MD, is a Staff Pathologist in the Department of Anatomic Pathology, located on the Main Campus of Cleveland Clinic. He was appointed in 1993 after serving as Associate Professor of Pathology at the Medical College of Ohio, Toledo. He completed a combined residency in anatomic and clinical pathology, with subspecialty training in cardiovascular pathology, at the Division of Laboratory Medicine of Cleveland Clinic.
Dr. Myles’ special interests include anatomic, clinical, cardiac, renal and lymph node pathology.
Dr. Myles received his medical degree from the Medical College of Ohio, Toledo. He was selected for an American Medical Association Nutrition Fellowship as a medical student from New England Deaconess Hospital, Boston.
He has served as co-investigator of two National Institute on Drug Abuse research trials on cardiotoxicity of cocaine. He has received numerous awards including the Medical Student Research Award and Golden Apple Award, from the Medical College of Ohio. Dr. Myles has served as a Physician Monitor for both the State Medical Board of Ohio and the Ohio Physicians Health Program. He is a Diplomate of Anatomic/Clinical Pathology of the American Board of Pathology, and a Diplomate of the National Board of Medical Examiners.
Education & Board Certifications
Education
- Residency: Cleveland Clinic, 1987
- Medical Education: Medical College of Ohio at Toledo, 1983
- Undergraduate: West Virginia University, 1980
Board Certifications
- Anatomic & Clinical Pathology: American Board of Pathology, 1987
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-10-03, Dr. Myles has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.